Long-acting β-agonist prescribing in people with asthma in primary care. / Morales, Daniel R; Jackson, Cathy; Fielding, Shona; Guthrie, Bruce.
In: Thorax, Vol. 68, No. 2, 01.02.2013, p. 192-194.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Long-acting β-agonist prescribing in people with asthma in primary care
A1 - Morales,Daniel R
A1 - Jackson,Cathy
A1 - Fielding,Shona
A1 - Guthrie,Bruce
AU - Morales,Daniel R
AU - Jackson,Cathy
AU - Fielding,Shona
AU - Guthrie,Bruce
PY - 2013/2/1
Y1 - 2013/2/1
N2 - Long-acting ß2-agonist (LABA) monotherapy is contraindicated in asthma following reports of serious adverse events. Anonymised Scottish health data were used to determine the prevalence of LABA prescribing and LABA monotherapy (sustained and episodic) in asthma during 2006. Of 73 486 asthma patients identified, 5592 (7.6%; 95% CI 7.4% to 7.8%) were prescribed LABAs as a separate inhaler of which 991 patients had LABA monotherapy (17.7% (95% CI 16.7% to 18.7%) of patients at risk). Asthma reviews were associated with reductions in sustained (OR 0.44; 95% CI 0.32 to 0.61) but not episodic monotherapy (OR 1.16; 95% CI 0.85 to 1.57). These findings support recent changes in UK asthma guidelines recommending LABAs in fixed-dose combination inhalers.
AB - Long-acting ß2-agonist (LABA) monotherapy is contraindicated in asthma following reports of serious adverse events. Anonymised Scottish health data were used to determine the prevalence of LABA prescribing and LABA monotherapy (sustained and episodic) in asthma during 2006. Of 73 486 asthma patients identified, 5592 (7.6%; 95% CI 7.4% to 7.8%) were prescribed LABAs as a separate inhaler of which 991 patients had LABA monotherapy (17.7% (95% CI 16.7% to 18.7%) of patients at risk). Asthma reviews were associated with reductions in sustained (OR 0.44; 95% CI 0.32 to 0.61) but not episodic monotherapy (OR 1.16; 95% CI 0.85 to 1.57). These findings support recent changes in UK asthma guidelines recommending LABAs in fixed-dose combination inhalers.
UR - http://www.scopus.com/inward/record.url?partnerID=yv4JPVwI&eid=2-s2.0-84872686039&md5=8e65ca2e00ffa3bb6fea75784d77485a
U2 - 10.1136/thoraxjnl-2012-202071
DO - 10.1136/thoraxjnl-2012-202071
M1 - Article
JO - Thorax
JF - Thorax
IS - 2
VL - 68
SP - 192
EP - 194
ER -